Drug – bio-affecting and body treating compositions – Inorganic active ingredient containing – Heavy metal or compound thereof
Reexamination Certificate
2006-04-25
2006-04-25
Jiang, Shaojia Anna (Department: 1617)
Drug, bio-affecting and body treating compositions
Inorganic active ingredient containing
Heavy metal or compound thereof
C424S641000, C424S678000, C424S682000
Reexamination Certificate
active
07033615
ABSTRACT:
Methods and compositions are provided for decreasing PGE2:PGF2α, regulating ratios of zinc:cadmium and regulating the concentration of zinc, calcium and zinc-containing and PGE2-dependent matrix metalloproteinases in body fluids and tissues of a human. Elevated or otherwise unregulated levels of PGE2, zinc and calcium and elevated concentrations of zinc-containing and PGE2-dependent matrix metalloproteinases have been found to be associated with the development of certain diseases.
REFERENCES:
patent: 4225592 (1980-09-01), Lakatos et al.
patent: 5130298 (1992-07-01), Cini et al.
patent: 5994337 (1999-11-01), Washburn et al.
patent: WO 88/03805 (1988-06-01), None
patent: WO 96/06836 (1996-03-01), None
Jacobson et al. British Journal of Nutrition, (Jan. 1977) 37 (1) 107-26.
“Cadmium oxide” EPA Chemical Profiles, United States Environmental Protection Agency, Washington D.C. 20460, USA, Dec. 1985. 4p.
Nordberg et al. IARC Scientific Publications, (1992) vol. 118, No. Cadmium in the Human Environment, pp. 293-297.
Waalkes, Michael P. et al., “Further evidence of the tumor-suppressive effects of cadmium in the B6C3F mouse liver and lung: Late state vulnerabiliy of tumors to cadmium and the role of metallothionein,”J. Pharmacol. Exp. Ther(1993), 266(3), 1656-63.
Lee, Kang Bo et al., “Effect of cadmium on human ovarian cancer cells with acquired cisplatin resistance,”Cancer Lett. (Shannon, Ireland) (1995), 88(1), 57-66.
Waalkes, Michael P., “Anticarcinogenic effects of cadmium in review,”Met. Ions Biol. Med., Proc. Int. Symp. 3rd(1994), 137-42, Editors: Collery, Philippe, Publisher: Libbey, Montrouge, France.
Waalkes, Michael P., “Down-regulation of metallothionein expression in human and murine hepatocellular tumors: association with the tumor-necrotizing and antineoplastic effects of cadmium in mice,”J. Pharmacol. Exp. Ther. (1996), 277(2), 1026-1033.
Gachot et al., “Effects of Cadmium and Copper on Zinc Transport Kinetics by Isolated Renal Proximal Cells,”Biol. Trace Elem. Res., 35(2):93-103, 1992.
Watanabe et al., “Correlation of Cadmium, Copper, Manganese, and Zinc Levels in the Urine of People in Nonpolluted Areas,”J. Toxicol Environ. Health, 33(3):263-72, 1991.
Moon J., “The Role of Vitamin D in Toxic Metal Absorption: A Review,”J. Am. Coll. Nutr., 13(6):559-64, 1994.
Nomiyama et al., “Trace Elements in Cardio-Cerebrovascular Diseases,”Ann. N. Y. Acad. Sci., 676:308-26, 1993.
Ozdem et al., “The Effects of Short-Term Nifedipine Treatment on Responsiveness of Aortic Rings of Cadmium-Hypertensive Rats,”Clin. Exp. Hypertens., 21(4):423-40, 1999.
Pandya et al., “Accumulation and Interrelationship of Cadmium and Zinc in Human Kidney Cortex,”Environ. Res., 36(1):81-8, 1985.
Torra et al., “Cadmium and Zinc Relationships in the Liver and Kidney of Humans Exposed to Environmental Cadmium,”Sci. Total Environ., 170(1-2):53-7, 1995.
Whelton et al., “Hepatic Levels of Cadmium, Zinc and Copper in Multiparous, Nulliparous and Ovariectomized Mice fed either a Nutrient-Sufficient or -Deficient Diet Containing Cadmium,”Toxicology, 119(2):141-53, 1997.
Koizumi, “Relationship of Cadmium Accumulation to Zinc or Copper Concentration in Horse Liver and Kidney”Environmental Research49:104-114, 1989.
Vivoli et al., “Cadmium in Blood, Urine and Hair Related to Human Hypertension,”J. Trace Elem. Electrolytes Health Dis., 3:139-145, 1989.
Elinder et al., “Cadmium and Zinc Relationships,”Environmental Health Perspectives, 25:129-132, 1978.
Foulkes, E. C., “Interactions Between Metals in Rat Jejunum: Implications on the Nature of Cadmium Uptake,”Toxicology, 37:117-125, 1985.
Visser et al., “Cadmium Ion is a Non-Competitive Inhibitor of Red Cell Ca2+-ATPase Activity,”Biochimica et Biophysica Acta, 1152:26-34, 1993.
Gerard, J.P. et al., “Curative external beam radiotherapy for prostate carcinoma: results in 231 patients treated in Lyon,” Aust. N. Z. J. Surg., 69(10):707-711 (1999).
Fortier, A.H. et al., “Antiangiogenic activity of prostate-specific antigen,” J. Natl. Cancer Inst., 91(19):1635-1640 (1999).
Tremblay, C. et al., “Induction of prostaglandin G/H synthase-2 in a canine model of spontaneous prostatic adenocarcinoma,” J. Natl. Cancer Inst., 91(16):1398-1403 (1999).
Liang, J.Y. et al., “Inhibitory effect of zinc on human prostatic carcinoma cell growth,” Prostate, 0(3):200-207 (1999).
Garfinkel, L. and Mushinski, M., “U.S. cancer incidence, mortality and survival: 1973-1996,” Stat. Bull. Metrop. Insur. Co., 80(3):23-32 (1999).
Will, J.C. et al., “Is diabetes mellitus associated with prostate cancer incidence and survival,” Epidemiology, 10(3):313-318 (1999).
Roberts, R.O. et al., “Decline in prostate cancer mortality form 1980 to 1997, and an update on incidence trends on Olmsted County, Minnesota,” J. Urol., 161(2):529-533 (1999).
Hebert, J.R. et al., “Nutritional and socioeconomic factors in relation to prostate cancer mortality: a cross-national study,” J. Natl. Cancer Inst., 90(21):1637-1647 (1998).
Kakehi, Y., “[Epidemiology and clinical features of prostate cancer in Japan],” Nippon Rinsho, 56(8):1969-1973 (1998).
Zaichick, V.Y. et al., “Zinc In the human prostate gland: normal, hyperplastic and cancerous,” Int. Urol. Nephrol., 29(5):565-574 (1997).
Brys, M. et al., “Zinc and cadmium analysis in human prostate neoplasms,” Biol. Trace Elem. Res., 59(1-3):145-152 (1997).
Shibata, A. et al., “Serum levels of prostate-specific antigen among Japanese-American and Native Japanese men” J. Natl. Cancer Inst., 89(22):1716-1720 (1997).
Andersson, S.O. et al., “Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden,” Int. J. Cancer, 68(6):716-722 (1996).
Waalkes, M.P. et al., “Cadmium exposure in rats and tumors of the prostate,” IARC Sci. Publ., (118):391-400 (1992).
Picurelli, L. et al., “[Determination of Fe, Mg, Cu, and Zn in normal and pathological prostatic tissue],”Actas. Urol. Esp., 15(4):344-350 (1991).
Wynder, E.L. et al., “Comparative epidemiology of cancer between the United States and Japan. A Second look.” Cancer, 67(3):746-763 (1991).
Tsugane, S. et al., “Cancer incidence rates among apanese immigrants in the city of Sao Paulo, Brazil, 1969-1978,” Cancer Causes Control, 1(2):189-193 (1990).
Tsugane, S. et al., “Cancer mortality among Japanese residents of the city of Sao Paulo, Brazil,” Int. J. Cancer, 45(3):436-439 (1990).
Elqhany, N.A. et al., “Occupation, cadmium exposure, and prostate cancer,”Epidemiology, 1(2):107-115 (1990).
Ogunlewe, J.O. and Osegbe, D.N., “Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate,” Cancer, 63(7):1388-1392 (1989).
Kolonel, L.N. et al., “Diet and prostatic cancer: a case-control study in Hawaii,” Am. J. Epidemiol., 127(5):999-1012 (1988).
Elinder, C.G. et al., “Cancer mortality of cadmium workers,” Br. J. Ind. Med., 42(10):651-655 (1985).
Hoffmann, L. et al., “Carcinogenic effects of cadmium on the prostate of the rat,” J. Cancer Res. Clin. Oncol., 109(3):193-199 (1985).
Feustel, A. and Wennrich, R., “Determination of the distribution of zinc and cadmium in cellular fractions of BPH, normal prostate and prostatic cancers of different histologies by atomic and laser absorption spectrometry in tissue slices,” Urol. Res., 12(5):253-256 (1984).
Feustel, A. and Wennrich, R., “Zinc and cadmium in cell fractions of prostatic cancer tissues of different histological grading in comparison to BPH and normal prostate,” Urol. Res., 12(2):147-150 (1984).
Whelan, P. et al., “
CancEr2 Inc.
Jiang Shaojia Anna
Rothwell, Figg Ernst & Manbeck, PC
LandOfFree
Methods for regulating levels of zinc, cadmium and calcium... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for regulating levels of zinc, cadmium and calcium..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for regulating levels of zinc, cadmium and calcium... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595059